COVID-19: Study on mixing and matching Covaxin, Covishield shows better result, says ICMR

The Indian Council of Medical Research (ICMR) said that the study on mixing and matching of two COVID vaccines, namely Covaxin and Covishield, shows better results. “Study on mixing & matching of COVID vaccines, Covaxin&Covishield shows better result,” said ICMR.

“Immunisation with combination of an adenovirus vector platform-based vaccine followed by inactivated whole virus vaccine was not only safe but also elicited better immunogenicity,” said the study.

Earlier, a PTI report quoted the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) as saying that the purpose of this research study is to evaluate whether a person can be given two different vaccine shots or not.

“The SEC (subject expert committee) after detailed deliberations recommended granting permission to CMC, Vellore for conducting the phase-4 clinical trial covering 300 healthy volunteers for mixing of COVID-19 vaccines Covaxin and Covishield,” PTI had quoted a source as saying.

Meanwhile, India recorded 39,070 new COVID-19 cases and 491 related deaths in the last 24 hours on Sunday (August 8, 2021), informed the Ministry of Health and Family Welfare. The country now has registered a total of 3.19 crore coronavirus infections and has witnessed 4,27,862 fatalities, since the pandemic started.